Advarra published a trend report examining how protocols evolve over time, operational challenges across TAs, and historical amendment patterns to inform future study design.
Published
Signal category
Research & Knowledge
Quote
“Drawing on data from more than 30,000 clinical studies, the report examines: - How protocols evolve over time - Where operational challenges commonly emerge across TAs - How historical amendment patterns can inform future study design”
— Advarra team
Company
Advarra
We're making the protocol lifecycle intelligent.
- Industry
- Research Services
- Location
- Columbia, US
- Company size
- 1,864 employees
Advarra provides the platform, insights, and expertise that make clinical trials more efficient and connected. As the leading independent IRB, we bring more than 40 years of trusted oversight to the industry, setting the standard for ethical reviews while building the largest collection of digitized protocols and operational data. This combined intelligence guides the protocol’s entire journey—from design through review, activation, and conduct—fueling a smarter, more adaptive research ecosystem. Backed by decades of partnership with research sites, Advarra delivers the core systems and services that 50,000 investigators and their study teams depend on for optimal trial operations. Integrated with our solutions for study design, startup, and conduct, these capabilities create a collaborative technology platform trusted by sponsors and CROs globally. By designing AI-powered workflows that streamline operations, reduce administrative burden, and promote transparency for all study stakeholders, we’re reimagining what’s possible in clinical research.
Founded 1983